|
1
|
Semenza GL: Regulation of mammalian
O2 homeostasis by hypoxia-inducible factor 1. Annu Rev
Cell Dev Biol. 15:551–578. 1999. View Article : Google Scholar
|
|
2
|
Lee SW, Jeong HK, Lee JY, Yang J, Lee EJ,
Kim SY, Youn SW, Lee J, Kim WJ, Kim KW, et al: Hypoxic priming of
mESCs accelerates vascular-lineage differentiation through
HIF1-mediated inverse regulation of Oct4 and VEGF. EMBO Mol Med.
4:924–938. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Lee SW, Yang J, Kim SY, Jeong HK, Lee J,
Kim WJ, Lee EJ and Kim HS: MicroRNA-26a induced by hypoxia targets
HDAC6 in myogenic differentiation of embryonic stem cells. Nucleic
Acids Res. 43:2057–2073. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Lee SW, Lee YM, Bae SK, Murakami S, Yun Y
and Kim KW: Human hepatitis B virus X protein is a possible
mediator of hypoxia-induced angiogenesis in hepatocarcinogenesis.
Biochem Biophys Res Commun. 268:456–461. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Lee SW, Won JY, Kim WJ, Lee J, Kim KH,
Youn SW, Kim JY, Lee EJ, Kim YJ, Kim KW, et al: Snail as a
potential target molecule in cardiac fibrosis: Paracrine action of
endothelial cells on fibroblasts through snail and CTGF axis. Mol
Ther. 21:1767–1777. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Carmeliet P, Dor Y, Herbert JM, Fukumura
D, Brusselmans K, Dewerchin M, Neeman M, Bono F, Abramovitch R,
Maxwell P, et al: Role of HIF-1alpha in hypoxia-mediated apoptosis,
cell proliferation and tumour angiogenesis. Nature. 394:485–490.
1998. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Moulder JE and Rockwell S: Hypoxic
fractions of solid tumors: Experimental techniques, methods of
analysis, and a survey of existing data. Int J Radiat Oncol Biol
Phys. 10:695–712. 1984. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Folkman J: What is the evidence that
tumors are angiogenesis dependent? J Natl Cancer Inst. 82:4–6.
1990. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Holash J, Wiegand SJ and Yancopoulos GD:
New model of tumor angiogenesis: Dynamic balance between vessel
regression and growth mediated by angiopoietins and VEGF. Oncogene.
18:5356–5362. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Dimmeler S and Zeiher AM: Endothelial cell
apoptosis in angiogenesis and vessel regression. Circ Res.
87:434–439. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Hanahan D and Folkman J: Patterns and
emerging mechanisms of the angiogenic switch during tumorigenesis.
Cell. 86:353–364. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Folkman J: Seminars in Medicine of the
Beth Israel Hospital, Boston. Clinical applications of research on
angiogenesis. N Engl J Med. 333:1757–1763. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Neufeld G, Cohen T, Gengrinovitch S and
Poltorak Z: Vascular endothelial growth factor (VEGF) and its
receptors. FASEB J. 13:9–22. 1999.PubMed/NCBI
|
|
14
|
Friesel RE and Maciag T: Molecular
mechanisms of angiogenesis: Fibroblast growth factor signal
transduction. FASEB J. 9:919–925. 1995.PubMed/NCBI
|
|
15
|
Yotsumoto F, Tokunaga E, Oki E, Maehara Y,
Yamada H, Nakajima K, Nam SO, Miyata K, Koyanagi M, Doi K, et al:
Molecular hierarchy of heparin-binding EGF-like growth
factor-regulated angiogenesis in triple-negative breast cancer. Mol
Cancer Res. 11:506–517. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Semenza GL: Targeting HIF-1 for cancer
therapy. Nat Rev Cancer. 3:721–732. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Itoh N and Ornitz DM: Functional
evolutionary history of the mouse Fgf gene family. Dev Dyn.
237:18–27. 2008. View Article : Google Scholar
|
|
18
|
Itoh N and Ornitz DM: Fibroblast growth
factors: From molecular evolution to roles in development,
metabolism and disease. J Biochem. 149:121–130. 2011. View Article : Google Scholar :
|
|
19
|
Lee SW, Kim WJ, Choi YK, Song HS, Son MJ,
Gelman IH, Kim YJ and Kim KW: SSeCKS regulates angiogenesis and
tight junction formation in blood-brain barrier. Nat Med.
9:900–906. 2003. View
Article : Google Scholar : PubMed/NCBI
|
|
20
|
Lee SW, Jung KH, Jeong CH, Seo JH, Yoon
DK, Suh JK, Kim KW and Kim WJ: Inhibition of endothelial cell
migration through the down-regulation of MMP-9 by A-kinase
anchoring protein 12. Mol Med Rep. 4:145–149. 2011.PubMed/NCBI
|
|
21
|
Runkle EA and Mu D: Tight junction
proteins: From barrier to tumorigenesis. Cancer Lett. 337:41–48.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Ding I, Liu W, Sun J, Fenton B and
Okunieff P: Comparison and modulation of angiogenic responses by
FGFs, VEGF and SCF in murine and human fibrosarcomas. Comp Biochem
Physiol A Mol Integr Physiol. 132:17–25. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Hu S, Li L, Yeh S, Cui Y, Li X, Chang HC,
Jin J and Chang C: Infiltrating T cells promote prostate cancer
metastasis via modulation of FGF11→miRNA-541→androgen receptor
(AR)→MMP9 signaling. Mol Oncol. 9:44–57. 2015. View Article : Google Scholar
|
|
24
|
Zhuang Z, Jian P, Longjiang L, Bo H and
Wenlin X: Oral cancer cells with different potential of lymphatic
metastasis displayed distinct biologic behaviors and gene
expression profiles. J Oral Pathol Med. 39:168–175. 2010.
View Article : Google Scholar
|
|
25
|
Lee SW, Kim WJ, Jun HO, Choi YK and Kim
KW: Angiopoietin-1 reduces vascular endothelial growth
factor-induced brain endothelial permeability via upregulation of
ZO-2. Int J Mol Med. 23:279–284. 2009.PubMed/NCBI
|
|
26
|
Brennan K, Offiah G, McSherry EA and
Hopkins AM: Tight junctions: A barrier to the initiation and
progression of breast cancer? J Biomed Biotechnol. 2010:4606072010.
View Article : Google Scholar
|
|
27
|
Bouchagier KA, Assimakopoulos SF, Karavias
DD, Maroulis I, Tzelepi V, Kalofonos H, Karavias DD, Kardamakis D,
Scopa CD and Tsamandas AC: Expression of claudins-1, -4, -5, -7 and
occludin in hepatocellular carcinoma and their relation with
classic clinicopathological features and patients' survival. In
Vivo. 28:315–326. 2014.PubMed/NCBI
|
|
28
|
Nissi R, Talvensaari-Mattila A, Kuvaja P,
Pääkkö P, Soini Y and Santala M: Claudin-5 is associated with
elevated TATI and CA125 levels in mucinous ovarian borderline
tumors. Anticancer Res. 35:973–976. 2015.PubMed/NCBI
|
|
29
|
Soini Y, Eskelinen M, Juvonen P, Kärjä V,
Haapasaari KM, Saarela A and Karihtala P: Strong claudin 5
expression is a poor prognostic sign in pancreatic adenocarcinoma.
Tumour Biol. 35:3803–3808. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Sugimoto H, Nagahara M, Bae Y, Nakagawa T,
Ishikawa T, Sato T, Uetake H, Eishi Y and Sugihara K:
Clinicopathologic relevance of claudin 5 expression in breast
cancer. Am J Clin Pathol. 143:540–546. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Kleeff J, Shi X, Bode HP, Hoover K,
Shrikhande S, Bryant PJ, Korc M, Büchler MW and Friess H: Altered
expression and localization of the tight junction protein ZO-1 in
primary and metastatic pancreatic cancer. Pancreas. 23:259–265.
2001. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Yang Y, Sun M, Wang L and Jiao B: HIFs,
angiogenesis, and cancer. J Cell Biochem. 114:967–974. 2013.
View Article : Google Scholar
|
